Garheng Kong

Garheng Kong

DirectoratXeris Biopharma Holdings· In proxies 2023–2025

Garheng Kong sits on 11 public boards.

Experience

  1. Xeris Biopharma HoldingsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +809%
  2. NephewPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  3. Lunit, Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  4. StrongbridgePublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  5. Laboratory Corporation of America HoldingsPublic company · 13 yr
    • Director2013 – Present · 13 yrNo stock prices for these years
  6. Smith+NephewPublic company
    • Director? – PresentNo stock prices for these years
  7. Melinta TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  8. Venus Concept, Inc.Public company · 7 yr
    • Director2017 – 2024 · 7 yrNo stock prices for these years
  9. Alimera Sciences, Inc.Public company · 11 yr
    • Director2012 – 2023 · 11 yrNo stock prices for these years
  10. Avedro, Inc.Public company · 2 yr
    • Director2017 – 2019 · 2 yrNo stock prices for these years
  11. Histogenics CorporationPublic company · 7 yr
    • Director2012 – 2019 · 7 yrNo stock prices for these years
  12. Cempra PharmaceuticalsPublic company · 13 yr
    • Director2006 – 2019 · 13 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?